Difference between revisions of "Schott AF, et al. Clin. Cancer Res. (2013) cited as Ref 579 in DOI: 10.1038/s41392-020-0110-5 (Q9842)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: DOI Identifier (P138): 10.1158/1078-0432.CCR-11-3326, #quickstatements; #temporary_batch_1590000649558)
(‎Created claim: Page(s) (P105): 1512-1524, #quickstatements; #temporary_batch_1590074839150)
 
(5 intermediate revisions by the same user not shown)
Property / PubMed ID
 +
Property / PubMed ID: 23340294 / rank
 +
Normal rank
Property / Publication Date
 +
2013
Timestamp+2013-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2013 / rank
 +
Normal rank
Property / Published In Name String
 +
Clin. Cancer Res.
Property / Published In Name String: Clin. Cancer Res. / rank
 +
Normal rank
Property / Volume
 +
19
Property / Volume: 19 / rank
 +
Normal rank
Property / title
 +
Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors (English)
Property / title: Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors (English) / rank
 +
Normal rank
Property / Page(s)
 +
1512-1524
Property / Page(s): 1512-1524 / rank
 +
Normal rank

Latest revision as of 15:45, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Schott AF, et al. Clin. Cancer Res. (2013) cited as Ref 579 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Schott AF
    0 references
    0 references
    2013
    0 references
    Clin. Cancer Res.
    0 references
    19
    0 references
    Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors (English)
    0 references
    1512-1524
    0 references